Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?-Reference-Cited by-同舟云学术

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?

Published:2017-01-04 Issue:1 Volume:18 Page:85
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Toss Angela,Venturelli Marta,Peterle Chiara,Piacentini Federico^ORCID,Cascinu Stefano,Cortesi Laura

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/1/85/pdf

Reference154 articles.

1. Twenty-years experience withde novometastatic breast cancer

2. Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature

3. Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer

4. Long term survival with metastatic breast cancer (MBC): Results of a retrospective, single-centre analysis from 2000–2005;Cnossen;Anticancer Drugs,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in inflammation and pathogen-associated interactions;Journal of Innate Immunity;2024-01-17

2. Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients;Breast Cancer Research and Treatment;2023-12-06

3. Analysis of Turkish Breast Cancer Patients With ATM-Heterozygous Germline Mutation According to Clinicopathological Features;Cureus;2023-10-19

4. The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking;Diagnostics;2023-09-15

5. IDENTIFICATION AND SCREENING OF PLANT-BASED POTENT INHIBITORS AGAINST nSH₂ DOMAIN OF PI3K OF BREAST CANCER USING DOCKING AND SIMULATION STUDIES;Biomedical Engineering: Applications, Basis and Communications;2023-08-25